Convergence Chemicals Profile
Key Indicators
- Authorised Capital ₹ 85.00 Cr
- Paid Up Capital ₹ 70.01 Cr
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 240.00 Cr
About Convergence Chemicals
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100MH2014PTC373507
- Company No.
081290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2014
- Date of AGM
17 Sep 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Convergence Chemicals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Divya Taldar | CFO | 03-May-2021 | Current |
| Akshita Jain | Company Secretary | 03-Sep-2021 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Valsaraj  | Director | 19-Nov-2014 | Current |
| Surinder Gulati | Director | 27-Apr-2015 | Current |
Financial Performance of Convergence Chemicals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Convergence Chemicals?
Unlock access to Convergence Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Piramal Pharma LimitedVivek Valsaraj is a mutual person
- Piramal Pharma Ii Private Limited
Surinder Gulati and Akshita Jain are mutual person
Abbvie Therapeutics India Private LimitedVivek Valsaraj is a mutual person
Charges (Loans)
₹240.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 240.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2021 | Axis Bank Limited | ₹30.00 Cr | Open |
| 15 Sep 2021 | Axis Bank Limited | ₹95.00 Cr | Open |
| 07 Nov 2019 | Axis Bank Limited | ₹115.00 Cr | Open |
How Many Employees Work at Convergence Chemicals?
Unlock and access historical data on people associated with Convergence Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Convergence Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Convergence Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
